Vest Financial LLC raised its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 21.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,998 shares of the business services provider's stock after purchasing an additional 16,455 shares during the quarter. Vest Financial LLC owned 0.05% of Genpact worth $4,181,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of G. Sumitomo Mitsui Trust Group Inc. bought a new stake in Genpact during the 1st quarter valued at $115,807,000. Clark Capital Management Group Inc. purchased a new position in Genpact during the 1st quarter worth $64,842,000. Ameriprise Financial Inc. boosted its holdings in Genpact by 109.8% during the 1st quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider's stock worth $81,375,000 after acquiring an additional 845,393 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Genpact by 20.9% during the 1st quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider's stock worth $207,129,000 after acquiring an additional 710,704 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Genpact by 421.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 767,386 shares of the business services provider's stock worth $38,662,000 after acquiring an additional 620,201 shares during the last quarter. Institutional investors own 96.03% of the company's stock.
Analyst Ratings Changes
A number of research firms have issued reports on G. Mizuho lifted their price objective on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Needham & Company LLC lifted their price objective on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Genpact in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a report on Thursday, July 17th. They set a "hold" rating and a $47.00 price objective on the stock. Finally, JPMorgan Chase & Co. cut their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a report on Wednesday, August 20th. Three research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $52.29.
Check Out Our Latest Research Report on G
Insider Activity
In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of the company's stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares of the company's stock, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Piyush Mehta sold 76,902 shares of the company's stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the sale, the senior vice president directly owned 134,880 shares in the company, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.
Genpact Price Performance
Shares of NYSE:G opened at $39.54 on Tuesday. The company's 50-day moving average is $42.91 and its 200 day moving average is $44.44. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. The company has a market capitalization of $6.89 billion, a P/E ratio of 13.14, a price-to-earnings-growth ratio of 1.35 and a beta of 0.89. Genpact Limited has a fifty-two week low of $37.82 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping analysts' consensus estimates of $0.85 by $0.03. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.23 billion. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm's quarterly revenue was up 6.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, equities research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, December 9th. This represents a $0.68 annualized dividend and a yield of 1.7%. Genpact's dividend payout ratio is 22.59%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report